Sort by
Refine Your Search
-
. Empa is a research institution of the ETH Domain. You will join an interdisciplinary SNSF Sinergia research project involving three Swiss partner institutions. The project aims to explore plasmonic
-
project on multifunctional self-sensing probe technologies for experiments on quantum materials under cryogenic and vacuum conditions. Main duties and responsibilities The successful candidate will work
-
duties and responsibilities Conducting research on network abstractions, spanning language design, implementation, and verification. The precise focus will be discussed with the successful candidate
-
molecules targeting relevant signaling nodes in the mentioned pathologies. The working place of the successful candidate is the Department of Biomedicine at Mattenstrasse 28, 4057 Basel. Project: The aim
-
postdoctoral position is available in the laboratory of Prof. Alex Persat (EPFL School of Life Sciences, https://www.p-lab.science/ ) to establish a new image-based drug screening platform targeting gram
-
of an Anosov representation. For instance, the boundary at infinity of a hyperbolic group naturally embeds as a subset of a flag manifold for an Anosov representation. The AnSur project aims to study the global
-
Conversion focuses on materials and device innovation for sustainable energy conversion and storage technologies. The research project focuses on the development of solid electrode composites, so-called
-
indoor air quality, aerosol science, exposure science, and healthy buildings. Projects may combine controlled laboratory experiments, measurements in real-world buildings, data analysis, and modeling
-
improving the security of modern computer systems. To do that, we often build novel analysis techniques to uncover previously-unknown attack surfaces and when appropriate we design and implement new systems
-
protocols. In close collaboration with the lab of George Coukos (https://agora-cancer.ch/laboratory/coukos-lab/ ), we will derive protocols enabling rapid expansion of cancer-specific, autologous TILs